U.S. Life Sciences Stock News

Why LyondellBasell Industries (LYB) is back on investors’ radar LyondellBasell Industries (LYB) has jumped into focus after tighter North American polyethylene inventories, moderating natural gas feedstock costs and stronger oxyfuels margins coincided with the company outperforming its recent cash improvement target. See our latest analysis for LyondellBasell Industries. That backdrop has coincided with sharp share price momentum, with a 7 day share price return of 15.27% and a 90 day share...

Earnings reaction puts Dole (DOLE) under closer investor scrutiny Dole (DOLE) recently reported quarterly revenue of US$2.37b, up 9.2% year on year and ahead of forecasts, but EBITDA and gross margins fell short of expectations, and the stock is down 10% since the release. See our latest analysis for Dole. At a share price of US$14.39, Dole’s recent 30 day share price return of 10.29% and 90 day share price return of 3.62% contrast with a 3 year total shareholder return of 27.32%. This...

In March 2026, Thermo Fisher Scientific announced a collaboration with SHL Medical to build an integrated U.S. hub in Ridgefield for sterile fill-finish, autoinjector assembly, and commercial packaging of patient-friendly injectable therapies, complementing its global sterile manufacturing network. This move deepens Thermo Fisher’s role as an end-to-end partner for pharma and biotech customers by linking drug manufacturing directly to finished self-injection devices in a single, scalable...

Sieve Capital’s public challenge to Americold Realty Trust (COLD) leadership, including a call to remove Chairman Mark Patterson and review all alternatives, such as a possible sale, has put governance and future direction in sharp focus for shareholders. See our latest analysis for Americold Realty Trust. The activist spotlight arrives after a tough stretch for investors, with a 1-year total shareholder return of about a 43% decline and a 5-year total shareholder return of about a 64%...

PENN Entertainment has opened the new US$360 million land-based Hollywood Casino Aurora across from Chicago Premium Outlets, nearly doubling its local workforce to about 700 people and preparing to transfer operations from its older riverboat site pending final regulatory approvals and funding support from Gaming and Leisure Properties and the City of Aurora. This expansion deepens PENN’s presence in the competitive Chicagoland casino corridor while highlighting its asset-light funding model...

Alexandria Real Estate Equities, Inc. (NYSE: ARE) was removed from the FTSE All-World Index (USD) on 21 March 2026, potentially affecting how index-tracking funds and other benchmarked investors hold the stock. This index removal highlights how Alexandria’s exposure to passive investment flows can influence trading activity independently of its underlying life science real estate fundamentals. Now, we’ll examine how Alexandria’s removal from the FTSE All-World Index may affect its investment...

Ingles Markets (IMKT.A) is in the middle of a contested proxy fight as Summer Road LLC challenges the board slate and executive pay, just weeks before the April 30, 2026 shareholder meeting. See our latest analysis for Ingles Markets. Recent activism and the latest dividend affirmation are playing out against a strong run in the shares, with a 90 day share price return of 31.01% and a 1 year total shareholder return of 39.58%, suggesting momentum has been building rather than fading. If this...

In March 2026, Celcuity reported that its full-year 2025 net loss widened to US$177.04 million, or US$3.79 per share, while management emphasized the FDA’s earlier acceptance of its gedatolisib New Drug Application with priority review and a July 17, 2026 PDUFA date. The company also indicated it has largely completed building out its sales force and internal systems, underscoring how regulatory progress on gedatolisib is being matched by concrete steps toward commercial readiness. Next,...

Suburban Propane Partners, L.P. recently expanded its partnership with NASCAR to now cover 21 tracks nationwide, including the past event at the U.S. Naval Base in Coronado and the renewed engagement at Chicagoland Speedway, supplying energy for race operations, concessions, and campgrounds. This broader NASCAR footprint highlights Suburban Propane’s growing role as a behind-the-scenes energy provider for large live events, reinforcing its positioning in dependable, on-the-ground fuel...

In late March 2026, iQIYI, Inc. outlined several corporate moves, including a proposed Main Board listing on the Hong Kong Stock Exchange, board approval of a new US$100 million share repurchase program over 18 months, and the start of open commercial testing for its Nadou Pro AI agents for professional long-form video generation. Together, the Hong Kong listing plan, buyback authorization, and AI video initiative highlight how iQIYI is simultaneously pursuing broader capital access, capital...

Danaher Corporation recently presented at the BIO-Europe Spring 2026 conference in Lisbon on March 24, 2026, with Senior Director Luciano Lucas speaking to an audience focused on biopharma partnering and innovation. This appearance gives Danaher a platform to highlight its life sciences tools and diagnostics capabilities to prospective collaborators and customers in a highly specialized setting. We’ll now examine how Danaher’s BIO-Europe Spring presentation, emphasizing its life sciences and...

Jack Henry & Associates (JKHY) is back in focus after Zelle expanded its Minority Depository Institution access program through a new partnership with the fintech provider, and Independent Bancshares Inc. selected Jack Henry to upgrade its core technology. See our latest analysis for Jack Henry & Associates. Despite the recent Zelle expansion and new bank wins, Jack Henry & Associates' 1-day share price return of 2.04% comes after a weaker patch, with a 90-day share price return of a 15.24%...

Virgin Galactic Holdings (SPCE) has created a new Chief Growth Officer role and appointed Megan Prichard. She has been tasked with leading revenue and expansion efforts across spaceflight expeditions, research missions, spaceports, partnerships, and new commercial markets. See our latest analysis for Virgin Galactic Holdings. The share price has retreated to US$2.17, with a 30 day share price return of a 14.90% decline and a 34.24% decline over 90 days. The 5 year total shareholder return of...

Ultragenyx Pharmaceutical (RARE) recently reported that the U.S. Food and Drug Administration cleared its Investigational New Drug application for UX016, a potential substrate replacement therapy for GNE myopathy, and a Phase 1/2 study is planned for 2026. See our latest analysis for Ultragenyx Pharmaceutical. Despite the UX016 milestone, the recent 30 day share price return of 17.49% decline and year to date share price return of 18.22% decline sit against a 1 year total shareholder return...

GameStop Corp. recently reported results for the fourth quarter and full year ended January 31, 2026, with quarterly sales of US$1,104.3 million versus US$1,282.6 million a year earlier and quarterly net income of US$127.9 million versus US$131.3 million. Despite lower sales both in the quarter and across the full year, full-year net income rose to US$418.4 million, lifting earnings per share from continuing operations compared with the prior year. Next, we’ll examine how GameStop’s higher...

Tokenization could enable faster settlement, increased liquidity and broader global investor access for Eva Live.

Missile attacks on major Middle East aluminum producers have disrupted material supply and pushed aluminum prices higher in recent days. These disruptions are drawing fresh attention to US based producer Alcoa (NYSE:AA) as investors reassess supply risk and potential margin effects. The renewed focus comes after earlier commentary around aluminum markets centered on easing supply and related price pressure. For Alcoa at a share price of $63.22, the new supply shock lands on top of a strong...

If you are wondering whether USA Compression Partners at around US$27.29 is priced attractively or not, the key is to separate share price excitement from underlying value. The unit price is down 2.4% over the last 7 days and 0.1% over the last 30 days, yet it still shows a 14.7% return year to date and 10.3% over the past year, with longer term returns of 66.1% over 3 years and 207.2% over 5 years. These moves sit against a backdrop of ongoing interest in energy infrastructure partnerships...

Guardian Investigate launch puts Cellebrite DI (CLBT) in focus Cellebrite DI (NasdaqGS:CLBT) is drawing fresh attention after launching Guardian Investigate worldwide, an AI-powered case management tool designed to help law enforcement teams organize, analyze and collaborate on complex digital investigations. See our latest analysis for Cellebrite DI. The Guardian Investigate launch comes after a mixed period for the stock, with a 1-day share price return of 2.16% to US$13.23, a 90-day share...

Merck (NYSE:MRK) reported positive Phase 3 results for its oral PCSK9 inhibitor, enlicitide decanoate, showing marked LDL C reduction and a favorable safety profile. The company also released Phase 2 WINREVAIR data in combined post and precapillary pulmonary hypertension with heart failure, supporting further clinical development. These readouts highlight potential franchise expansion for Merck in cardiovascular and cardiopulmonary diseases, extending beyond its existing oncology focus. For...

Worthington Steel, Inc. has already reported its third-quarter and nine-month results to February 28, 2026, showing higher sales of US$769.8 million for the quarter and US$2.51 billion for nine months, but with quarterly net income easing to US$10.4 million while nine‑month earnings improved to US$66 million; the board also declared a US$0.16 per‑share dividend payable on June 26, 2026. The mix of rising revenue but softer quarterly profitability, alongside a maintained dividend, highlights...

GBank Financial Holdings (GBFH) just closed out FY 2025 with fourth quarter revenue of US$20.9 million and basic EPS of US$0.52, supported by trailing twelve month revenue of US$72.2 million and EPS of US$1.46. Over recent periods, quarterly revenue has moved from US$16.2 million in Q4 2024 to US$20.9 million in Q4 2025, while quarterly EPS shifted from US$0.37 to US$0.52. This may prompt investors to focus on how earnings power and profit margins are holding up. See our full analysis for...

ADMA Biologics (ADMA) moved back into focus after its shares climbed about 11% following a detailed rebuttal to a short seller report that questioned ASCENIV demand and alleged aggressive distribution practices. See our latest analysis for ADMA Biologics. That sharp 11% rebound sits against a weak recent trend, with a 30-day share price return of 41.23% and a year to date share price return of 48.83%. At the same time, the 3-year total shareholder return of about 1.8x and 5-year total...

Wondering if Constellation Energy at around US$298 a share is priced for perfection or still offers value? This article breaks down what the current market price might be saying about the stock. The share price is up 1.3% over the past week, after a 9.5% decline over 30 days and an 18.5% pullback year to date, while the 1 year return sits at 45.0% and the 3 year return at 301.7%. Recent headlines around Constellation Energy have focused on its role in the US power market and investor...